Optimizing Study Design for Clinically Useful Peripheral Molecular Biomarker Discovery in Psychiatry: A Review

Area of Science:

• Biomarker Discovery
• Psychiatric Research
• Translational Medicine

Background:

• Current psychiatric diagnosis relies on subjective assessments.
• Peripheral biomarkers offer potential for objective patient stratification and scalable clinical care.
• Omics technologies and increased funding present an opportunity for molecular biomarker discovery.

Purpose of the Study:

• To provide recommendations for optimizing peripheral psychiatric biomarker study design.
• To emphasize the critical role of study design in achieving robust and translatable biomarkers.
• To guide the field towards sustainable progress in biomarker research.

Main Methods:

• Narrative review of study design principles for peripheral psychiatric biomarkers.
• Discussion of triangulating clinical utility, technological fit, and biological plausibility.
• Emphasis on optimizing signal-to-noise ratio and minimizing biological/technical noise.

Main Results:

• Study design is the most critical factor for successful biomarker discovery.
• Feasibility constraints impact data collection and analysis for biomarker studies.
• Careful phenotype selection and noise minimization are crucial for signal detection.

Conclusions:

• Prioritizing proof-of-principle study designs is essential for the sustainability of psychiatric biomarker research.
• No technological or analytical advances can compensate for a poorly designed dataset.
• Optimized study designs are key to realizing the potential of peripheral biomarkers in psychiatry.